Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and/or inducing weight loss in patients in need thereof particularly in individuals having a contraindication for treatment with biguanide compounds are provided comprising administering delayed release formulations of such biguanide compounds including metformin targeted to the small intestine.